Literature DB >> 15351489

The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function.

Kamana Parashar Misra1, Atish Mukherji, Vijay Kumar.   

Abstract

The X protein of hepatitis B virus or HBx is a multifunctional regulatory protein that carries the fame of a promiscuous transactivator. Although, the N-terminal 'A' region of HBx (amino acids 1-20) is the most conserved region among mammalian hepadnavirus genomes, it has been found to be dispensable for transactivation function [Proc. Natl. Acad. Sci. U.S.A. 93, 1996, 5647]. To elucidate its biological role, DNA sequence corresponding to the A region of X gene was amplified by polymerase chain reaction and cloned as a 72 base pair HBx mutant X17. In order to augment the intracellular biochemical stability of the expressed protein, the monomeric X17 was multimerized and 2-10 units long tandem repeats of the A region (X17-n) were cloned in a mammalian expression vector. Expression of the X17 constructs was confirmed by in vitro transcription and translation, as well as by RT-PCR after transfection in hepatoma cells. The function of X17 was investigated using the chloramphenicol acetyl transferase reporter constructs of viral (RSV-LTR, HIV1-LTR and HBx) and cellular gene promoters (c-Jun and epidermal growth receptor). Not only did the X17 multimers inhibit the HBx-mediated transactivation of all the reporter genes, but also their basal activities. The inhibition was dependent on the amount of X17 plasmid transfected in cells as well as on the number of repeat units present in the X17 expression vectors. Further, the X17-related inhibition of transactivation was not a cytotoxic effect. Thus, our data suggests that the N-terminal 'A' domain of HBx has a negative regulatory function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351489     DOI: 10.1016/j.virusres.2004.05.006

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection.

Authors:  József Pál; Zoltán Nyárády; Ilona Marczinovits; Alajos Pár; Younes Saleh Ali; György Berencsi; Krisztián Kvell; Péter Németh
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

2.  The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation.

Authors:  Xiaoyu Fu; Deming Tan; Zhouhua Hou; Zhiliang Hu; Guozhen Liu; Yi Ouyang; Fei Liu
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

3.  Hepatitis B Virus X Protein Function Requires Zinc Binding.

Authors:  Dhivya Ramakrishnan; Weimei Xing; Hyock Joo Kwon; Simon P Fletcher; Rudolf K Beran; Saketh Chemuru; Henry Rohrs; Anita Niedziela-Majka; Bruno Marchand; Upasana Mehra; Aleš Zábranský; Michal Doležal; Martin Hubálek; Iva Pichová; Michael L Gross
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  Accurately mapping the location of the binding site for the interaction between hepatitis B virus X protein and cytochrome c oxidase III.

Authors:  Dan Li; Jian Ding; Zhixin Chen; Yun Chen; Na Lin; Fenglin Chen; Xiaozhong Wang
Journal:  Int J Mol Med       Date:  2014-12-02       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.